Clinical Trial Update: Repurposing Bromocriptine for Abeta Metabolism in Alzheimer's Disease [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluated repurposing bromocriptine to influence beta-amyloid metabolism in Alzheimer's disease, including familial Alzheimer's disea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Bromocriptine (bromocriptine)

Snippet

Sponsor: Kyoto University | Conditions: Familial Alzheimer Disease (FAD), PSEN1 Mutation | Phase 1, Phase 2 | Status: COMPLETED